Fast pathway ablation in a patient with PR prolongation
Randa Tabbah1, Bernard Abi-Saleh2
1Departement of Cardiology, Holy Spirit University, Beirut, Lebanon.
Pacing and Clinical Electrophysiology : PACE
|June 14, 2020
Summary
Fast pathway ablation is a viable treatment for typical atrioventricular node reentrant tachycardia (AVNRT) in patients with a long PR interval. This approach avoids risks associated with slow pathway ablation in specific patient groups.
Area of Science:
- Electrophysiology
- Cardiology
- Cardiac Arrhythmias
Background:
- Typical atrioventricular node reentrant tachycardia (AVNRT) usually involves slow-fast pathways, with slow pathway ablation as standard therapy.
- Patients with long PR intervals or reliance on the slow pathway require alternative ablation strategies to prevent atrioventricular block.
Observation:
- A 42-year-old female with restrictive cardiomyopathy and prior ablations presented with incessant narrow complex tachycardia suggestive of AVNRT.
- Baseline EKG showed a prolonged PR interval (320 ms), and electrophysiology study revealed no anterograde fast pathway conduction.
Findings:
- Radiofrequency ablation targeting the retrograde fast pathway in the anteroseptal region successfully terminated the tachycardia.
- Post-ablation, anterograde conduction persisted via the slow pathway, and the tachycardia was rendered uninducible.
Implications:
- Fast pathway ablation is an effective alternative for typical AVNRT in patients with prolonged PR intervals or impaired anterograde fast pathway conduction.
- This technique offers a safe and successful treatment option, preserving normal atrioventricular conduction.
- Case highlights the importance of individualized ablation strategies in complex cardiac arrhythmia management.
Related Concept Videos
Dysrhythmias IV: Characteristics of Bradyarrhythmias
373
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
373
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.7K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.7K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
1.4K
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.4K
Cardiac Action Potential
5.1K
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
5.1K


